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Purpose: This study was designed to define the effects of ~-adrenergic blockade on aortic 
lysyl oxidase (LO), an enzyme responsible for elastin and collagen cross-linking, and 
aneurysm formation in the blotchy mouse. It was hypothesized that G-blockade would 
inhibit the development of aneurysms because of its hemodynamic effect rather than a 
direct effect on LO activity. 
Methods: Three groups of mice were studied: group I -normal  littermates of blotchy mice; 
group I I -untreated blotchy mice; group I I I -b lotchy mice given either propranolol, 
atenolol, or nadolol. Data from the three different beta blocker-treated animals, group III, 
were statistically identical and were combined for analysis. The study was concluded when 
the mice were 4 months of  age. At that time systolic blood pressure, heart rate, and aortic 
diameters were measured, and the entire aorta from each mouse was subjected to a bioassay 
for LO activity. 
Results: Group I normal mice had an aortic arch diameter of 0.10 + 0.02 cm. Group II 
blotchy mice developed aortic arch aneurysms with a diameter of 0.21 + 0.03 cm. In 
Group III, 13 blockade reduced the aortic arch diameter in blotchy mice to 0.11 +-- 0.03 cm. 
Mean heart rate in group III [3-blocked mice was reduced 25% compared with group I
normal mice, and 18% compared with group II untreated blotchy mice. Blood pressures 
were similar in all three groups. Group II blotchy mice exhibited approximately half of the 
aortic LO activity (2.43---0.57 cpm/~g protein) noted in group I normal mice 
(5.82 _ 1.06 cpm/~g protein). Aortic LO activity in group III blotchy mice remained low 
(2.09 -4-_ 0.85 cpm/~g protein) despite administration of 13-blockers. 
Conclusions: This is the first study to document an actual decrease in the level of aortic LO 
activity in blotchy mouse. [3-Blockade inhibits development of aortic aneurysms inblotchy 
mice. This is associated with a reduction in heart rate, but not by alterations inLO activity. 
(J VASC SURG 1995;21:792-800.) 
Rupture of aortic aneurysms has ranked among 
the most common causes of  death in the United 
States during the past decade. Surgical resection 
before or at time of rupture has been the only 
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therapeutic option for these patients. However, there 
is evidence that pharmacologic therapy with 
[3-adrenergic blockers can delay or  prevent aneurysm 
formation both in experimental nimal models and in 
human beings, t4 The mechanism by which [3-block- 
ade inhibits aneurysm development and rupture has 
been the subject of considerable speculation. 
Male blotchy mice are one of the few animal 
models of spontaneous aortic aneurysmal disease. 
These mice display a phenotype consistent with a 
mixed connective tissue disorder that includes 
blotchy coat color, decreased tensile strength of skin, 
pulmonary emphysema, neurologic abnormalities, 
and aortic aneurysms, s-8 The pathophysiologic con- 
dition of  aneurysm formation in these mice has been 
attributed to a decrease in the activity of  lysyl oxidase 
(LO), a copper-dependent zyme. LO is considered 
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essential in cross-linking of elastin and collagen in 
vascular tissue. Before this investigation, LO activity 
had never been assayed in aortic tissue of blotchy 
mice. However, reduced LO activity had been docu- 
mented in lung, skin, and cultured fibroblasts of these 
animals. 9,m 
Propranolol has been reported by others to delay 
formation of aortic aneurysms in blotchy mice) 
Furthermore, propranolol administration has been 
noted to increase insoluble lastin and collagen in the 
skin of these mice, suggesting reater matrix cross- 
linking, n On the basis of these observations, it has 
been believed that the delay of  aneurysm formation 
by propranolol might be primarily due to a 
[3-blocker-induced direct effect on LO activity and, 
hence, matrix cross-linking. A considerable number 
of assumptions would need to be true if this were to 
be the case. 
The purpose of this study was to test the 
hypothesis that [3-blockers retard aortic aneurysm 
development in the blotchy mouse by hemodynamic 
changes, not by altered LO activity within the aortic 
wall. To test this hypothesis t was necessary first to 
document that blotchy mouse aortic tissue indeed 
demonstrated decreased LO activity and that this 
decrease correlated with aortic aneurysm formation. 
Subsequently, aortic LO activity and hemodynamic 
responses associated with [3-blocker administration i  
these mice were examined. Resolution of the issue of 
whether delayed aneurysm development accompany- 
ing ~ blocker administration is due to a hemody- 
namic effect or direct effect on LO activity is of 
importance in the clinical setting. 
MATERIAL AND METHODS 
Animal model. Male blotchy mice were bred by 
mating heterozygous female carriers of the blotchy 
gene with normal C57BL6 males, Homozygous 
blotchy males, distinguished by their coat color and 
size, and normal mate littermates were weaned at 
1 month of age. Animal care complied with the 
"Principles of Laboratory Animal Care" (National 
Society for Medical Research I, the Guide for the Care 
and Use of Laboratory Animals (NIH Publication No. 
86-23, revised 1985), and The University of Michi- 
gan Committee on the Use and, Care of Animals 
(Approval No. 4239A Mice). 
Experimental groups. Three groups of mice 
were studied: untreated normal male littermates of 
blotchy mice (group I) and untreated blotchy mice 
(group II) served as normal controls and blotchy 
controls, respectively. Additional blotchy mice were 
treated for 3 months with [3-blockers supplied in their 
drinking water once they were weaned, using pro- 
pranolol 0.05%, atenolol 0.05%, or nadolol 0.05% 
(group III). 
Hemodynamic and aortic measurements. Tail 
cuff systolic blood pressure (mm Hg) and heart rate 
(beats/min) were measured in mice at the termina- 
tion of the experiment when the mice were 4 months 
of age by use of an electrosphygmomanometer 
(Narco Bio-System, Houston, Texas). At that time 
each mouse was placedin aheated (37 ~ C) restraining 
device with the tail inserted into a pneumatic cuff and 
a pressure transducer applied to its ventral surface. 
Heart rate was determined by counting pulsewave 
deflections on the pressure recording. A photograph 
was then taken of the ascending aorta, aortic arch, 
and descending thoracic aorta before any blood loss. 
A ruby bead o f  known diameter was used for 
reference to calculate the aortic diameter. The dimen- 
sions of the ascending aorta just distal to the aornc 
valve and the descending aorta just beyond the 
crossover of the azygous Vein were recorded. The 
animals were killed, and the aorta was then removed 
from the aortic valve to the iliac bifurcation. This 
tissue in its entiretv was subjected to an analysis of 
LO activity. 
Aortic preparation. Individual mouse aortic 
extracts were prepared by first homogenizing the 
aortic tissue for 90 seconds in 0.5 ml of phosphate- 
buffered saline solution, 0.01 mot/L NaH2PO4/0.15 
mobil NaCl, pH 7.7 (NaCl/Pi). The homogenate 
was centrifuged (10,000 g, 20 minutes), and the 
pellet was again extracted inNaCbrPi and centrifuged. 
The pellet was again extracted and centrifuged three 
more times for I hour with 0.5 ml of 4 mol/L 
urea/0.05 mol/L Tris, pH 7.7. All extractions were 
performed at 4 ~ C. The supernatant from the three 
urea extracts were pooled and dialyzed against 2 L of 
NaClfPi in dialysis tubing (12,000 molecular weight 
cut off) for 2 hours. After dialysis, 100 r of each LO 
extract were removed for determination of total 
protein content with a BCA protein assay reagent 
(Pierce, Rockford, Ill. ). 
Lysyl oxidase assays. LO activity was measured 
with a tritium release assav. Tritium release was 
quantitated after oxidative deamination of aH-lysine 
residues in labeled chick embryo elastin on incuba- 
tion with LO extracted from individual mouse aortas 
as originally described by Pinnell and Martin 12 with 
modifications.13 Briefly, each individual mouse aortic 
extract was divided into six microcentrifuge tubes. 
These tubes contained 200 ~1 of LO extract and 100 
r of radioactivity labeled (aH-lysine) elastin sub- 
strate (approximately 100,000 counts per minute 
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[cpm], see details below). Three of these tubes had 
100 ~1 of [3-aminopropionitrile (BAPN 50 ~g/ml), a 
specific inhibitor of LO. Each tube was then flushed 
with oxygen, vortexed, and incubated in a shaker at 
37 ~ C for 20 hours. The reaction was stopped at 20 
hours by placing the tubes on ice and centrifugation 
(15,000 grams, 10 minutes), Tritiated water was 
microdistilled irectly into cooled scintillation vials 
by the method of Misiorowski, 14 with minor modi- 
fications. The tritiated water collected in each scin- 
tillation vial was then counted in a [3-scintillation 
counter (Beckman LS6000LL, Fullerton, Calif.). 
LO activity in the extracts was calculated as the 
amount of tritium released from the incubation 
mixture of mouse aortic extract and chick elastin 
substrate. LO activity was reported as cpm. In the 
case of each extract, cpm from the three samples 
without BAPN were averaged as one group. The cpm 
from the three samples with BAPN were averaged 
into another group to calculate nonspecific tritium 
release. The latter was used as a background correc- 
tion. Each averaged sample was normalized by 
correcting to the amount of protein in the 200 ~1 
sample of LO extract. LO activity for each aortic 
sample was then calculated by subtracting the radio- 
activity of samples with BAPN from the radioactivity 
of samples without BAPN. Thus LO activity is 
reported as cpm per ~g of aortic protein extracted. 
Preparation of the elastin substrate used in the LO 
activity assays deserves pecial note. Thirty 17-day- 
old, chick embryo aortas were removed and prein- 
cubated for 1 hour at 37 ~ C in 50 ml flasks containing 
sterile Dulbecco's modified essential medium (Gibco, 
Grand Island, N.Y.) without lysine but supple- 
mented with 50 mg/L alanine, 50 mg/L glycine, 50 
mg/L proline, 50 mg/L valine, 50 mg/L ascorbic 
acid, 10 s units/L penicillin, 100 mg/L streptomycin, 
and 50 mg/L BAPN to inhibit endogenous LO 
activity in the substrate. The media pH was adjusted 
to 7.4. The chick aortas were then incubated on an 
orbital shaker for 20 hours in 50 ml of the above 
medium containing 0.56 MBq/ml (4,5-3H) lysine 
(New England Nuclear, Wilmington, Del.) at 37 ~ C 
in an atmosphere of 5% CO2/95% air. The chick 
aortas were homogenized in 12 ml 0.15 mol/L NaC1 
and centrifuged (10,000 gm, 5 minutes) at 4 ~ C. The 
pellet was retained, and this extraction step was 
repeated. To inactivate ndogenous LO, the pellet 
was further homogenized in 1 N HCI and centri- 
fuged as above, is This step was repeated a second 
time. The pellet was then homogenized in buffer (0.1 
mol/L Na2B407, 0.15 mol/L NaCI, pH 8.0) and 
centrifuged as above. This step was repeated a second 
time. Finally, the pellet was resuspended in assay 
buffer to give a concentration of 100,000 cpm per 
100 ~1 ofsubstrate preparation. Aliquots containing 
approximately 600,000 cpm were dispensed into 
microcentrifuge tubes and stored at - 70 ~ C for later 
assays. Chick elastin substrate was not stored for 
longer than 60 days before its use in the LO activity 
assay. 
Statistical analysis. All data in this report are 
expressed as the mean _+ 1 SEM. No statistically 
significant differences were identified among mice 
receiving the three different [3-'blockers, and thus data 
from these mice were combined into group III for 
further analysis. Group differences were subjected to 
statistical analysis by use of analysis of variance 
(ANOVA), and a post hoc comparison with Fisher's 
protected least squares difference test (Statview 512, 
Abacus Concepts, Inc., Calabasas, Calif.). Signifi- 
cance was assigned when the F-test resuk for multi- 
comparison wasp < 0.05. 
RESULTS 
Aortic dimensions. Group II blotchy mice all 
developed aortic arch aneurysms by 4 months of age 
(mean diameter 0.21 + 0.03 cm) when compared 
with group I normal littermates (mean diameter 
0.10 + 0.01 cm, p = 0.0001), (Fig. 1). Group III 
blotchy mice treated with [3-blockers exhibited a 
significant 47% reduction (p = 0.0001) in their 
aortic diameter (0.11 _ 0.01 cm) compared with 
group II untreated blotchy mice. No difference in 
aortic size of group III 13-blocked blotchy mice 
existed when compared with group I normal mice. 
The ratio of the ascending aortic arch diameter to 
the descending thoracic aorta diameter was another 
means of documenting arch aneurysms (Fig. 2). This 
ratio was 1.3 _+ 0.1 in group I normal mice, whereas 
in group II blotchy mice it was 2.8 _+ 0.5, being 
significantly greater (p = 0.004). This ratio de- 
creased to near-normal levels of 1.6 _+ 0.1 in group 
III blotchy mice treated with [3-blockers, a size also 
significantly (p = 0.004) less than in group II mice. 
It is relevant hat blotchy mice did not develop 
aneurysms in the descending thoracic aorta and that 
the absolute diameter of this portion of aorta did not 
differ among the three groups (I to III) of mice 
(Fig. 3). 
Aortic lysyl oxidase activity. Whole aortic tissue 
LO activity (Fig. 4) in group II blotchy mice 
(2.43 + 0.57 cpm/~g protein) was approximately 
half the LO activity present in aortic tissue from 
group I normal mice (5.82 _+ 1.06 cpm/~g protein). 
This difference was significant (p = 0.0025). Aortic 
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figures represents number of animals or specimens analyzed 
in that specific group. 
LO activity in group III blotchy mice receiving 
[3-blockers (2.18 m 0.31 cpm/l~g protein) was not 
increased compared with untreated group II blotchy 
mice but was significantly less than that in group I 
normal mice (p -- 0.001). 
To confirm that the assay LO activity was not 
affected irectly by propranolol, an ancillary study 
was performed. The entire assay as previously de- 
scribed was repeated with aortic tissue from 
group II untreated blotchy mice, but the as- 
say incubation had propranolol directly added to 
it. Such an augmented assay did not result in al- 
tered LO activity measurements when compared 
with that without the added [3-blocker (data not 
shown). 
Hemodynamic effects. Evidence of the [3-block- 
ade was apparent in the relative bradycardia 
achieved in mice administered the [3-blockers (Fig. 
5). Heart rate averaged 699 + 16 beats/min in 
group I normal mice and 638 -+ 25 for group II 
blotchy mice. These heart rates were not statistically 
different. The [~-blockade in group III mice pro- 
duced a 25% reduction in heart rate to 521 -+ 17 
in comparison to group I normal mice (p = 0.002) 
and an 18% reduction compared with group II 
blotchy mice (p = 0.002). Systolic blood pressure 
did not differ among group I normal, group II 
untreated blotchy, and group III [~-blocked mice 
(Fig. 6). 
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Fig. 3. Descending thoracic aortic diameters. No signif- 
icant differences were detected between ormal mice and 
blotchy mice, whether given [3-blockers or not. 
DISCUSSION 
Mechanisms of aortic aneurysm development, 
enlargement, and rupture are not fully understood, 
but increasing evidence suggests that initial patho- 
logic events involve matrix defects. These defects 
precede the inflammatory and atherogenic changes 
that characterize aneurysms late in their evolution. 
Laboratory studies of the early events initiating 
aneurysmal development have been limited because 
of the rarity of nonprimate species spontaneously 
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Fig. 5. Comparison of heart rates. No statistically signif- 
icant difference was detected between group II blotchy 
(638 +- 25 beats/min) and group I normal mice (699 + 
16 beats/min). Group III blotchy mice treated with 
t3-blockers exhibited statistically significant reduction in 
heart rate (521 -+ 17 beats/min) compared with both 
blotchy and normal groups (p = 0.002). 
exhibiting these lesions. An exception is the blotchy 
mouse. Its genotype contains an allelic mutation at 
the mottled locus of the X chromosome that results 
in a deficiency in a copper transport protein. This 
affects all proteins that require copper as a cofactor to 
become fully active. One of these proteins is LO, the 
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Fig. 6. Comparison of systolic blood pressure. No statis- 
tical differences could be detected between ormal mice 
and blotchy mice, regardless of whether they were treated 
with [3-blockers. 
enzyme responsible for collagen and elastin cross- 
linking in the extracellular matrix of different issue 
types, including the aorta. 
Diminution in aortic LO activity in the 
genetically-impaired blotchy mouse is believed to 
result in inadequate cross-linking of matrix collagen 
and elastin. Aortic aneurysm formation occurs in 
100% of blotchy mice by 6 months of age. 2,7 These 
aneurysms tend to affect he proximal aorta most, as 
evident in the present study where the blotchy 
mouse's aortic arch at 4 months of age was clearly 
aneurysmal, having a mean diameter 108% larger 
than their normal ittermates (Fig. 1). 
The 1.3 : 1 ratio of the aortic arch to descending 
thoracic aortic diameter in normal mice increased to 
2.8 : 1 in blotchy mice, thus fillfilling the criterion of 
a focal aortic aneurysm. The basis for this localized 
aneurysmal change is not known but may relate to 
greater physical stresses affecting the proximal aorta 
as opposed to other areas of the aorta. This might 
necessitate greater matrix reformation, a requirement 
not met without normal levels of LO activity in aortic 
tissue. Similar stresses and impaired matrix cross- 
linking may account for the common infrarenal 
localization of human aortic aneurysms or isolated 
femoral and popliteal artery aneurysms occurring in 
male patients at sites of repetitive vessel stretch- 
stresses. 
Decreased LO activity has been demonstrated in 
skin and lung of affected blotchy mice and can explain 
the phenotypic abnormalities seen in these tissues. 9'1~ 
A 68% reduction in LO activity has been observed in 
lung tissue and appears associated with emphysema 
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normal and blotchy mouse aortas. Blotchy mouse SMC LO 
actiwty was significantly reduced to levels below that seen 
in normal mouse SMC ~p = 0.0364). 
in the blotchy mouse. Similarly, skin extracts in 
affected mice have exhibited a 69% reduction in LO 
activity compared with normal mice and appears 
associated with increased fragility of their skin. A 
genetically comparable human disease, Menke's yn- 
drome, exhibits tormosity and localized arterial 
dilations. Cultured fibroblasts from these patients 
exhibit a 74% reduction m LO activity compared 
with fibroblasts from normal patients. 16 Human 
aortic aneurysms are most likely to be infrarenal in 
location and when encountered clinically are associ- 
ated with atherosclerotic changes. Neither of these 
two fifidings charficterize blotchy mouse aneurysms. 
Nevertheless, the aneurysms in these mice provide a 
unique model to study pharmacologic interventions 
for arterial aneurysms in which an underlying defect 
exists in the vessel wall matrix. 
No report to date has documented in vivo levels 
of  aortic LO activity in blotchy mice. In addition, 
aortic aneurysm formation directly related to a 
deficiency in LO activity has never been documented. 
This investigation demonstrated that LO activity 
could be measured in individual mouse aortas and 
revealed a significant 59% reduction of LO activity in 
blotchy mouse aortas compared with normal mice. 
This reduction of LO activity in aortic tissue (Fig. 4) 
is consistent in magnitude to the reductions reported 
in other blotchy mouse tissues. 
Decreased LO activity in blotchy aortic tissue 
was the subject of other m vitro experiments from 
our laboratory, in which cultured aomc smooth 
muscle cells (SMC) had propranolol (1 limol/L) 
added to the culture media. SMC LO activity 
from blotchy mice was 61% less than that of 
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Fig. 8. Comparison of SMC derived from blotchy mice 
without and with addition of propranolol to culture media 
(repeated in triplicate). Propranolol did not alter LO 
activity. 
normal SMC (Fig. 7). This reduction was almost 
identical to the 59% reduction of LO activity 
measured in whole aortic tissue. Furthermore, 
the addition of propranolol to blotchy SMC did 
not alter LO activity in the culture media 
(Fig. 8). 
Previous investigations have documented that 
[~-btockade with propranolol may decrease aneurysm 
development and lessen the frequency of aneurysm 
rupture, In particular, f3-blockade in the blotchy 
mouse model has been reported to cause a 33% 
reduction of aortic diameter, as well as an increase in 
insoluble skin elastin and collagen. 2,7 The latter 
suggests greater matrix cross-linking. However, no 
direct measurements of LO activity or hemodynamic 
parameters were made in these studies. 
In a second model involving aortic dissections in 
the broad-breasted white turkey, [~-blockade with 
propranolol reduced BAPN-induced aortic rupture 
and raised the tensile strength of the abdominal 
aortaJ ,17,1s Propranolol's effect on aneurysm devel- 
opment was not believed to be due to the observed 
hemodynamic effects, a decrease in heart rate and 
blood pressure, but rather to be related to a direct 
effect on collagen and elastin matrix cross-linking 
through amodulation of the LO enzyme. As further 
support for a nonhemodynamic cause of aneurysm 
reduction, it was noted that hydralazine did not 
reduce rupture of turkey aortas, despite areduction in 
blood pressure.19 However, in as much as hydralazine 
did not change heart rate in these turkeys, and the fact 
that hydralazine is known to interfere with collagen 
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synthesis, the relevance of these findings is subject to 
question. 
Propranolol has also been shown to reduce the 
size of experimentally induced aortic aneurysms in 
genetically hypertensive Wistar-Kyoto rats. 2~ This 
effect was found to be independent of the dose and 
was considered to 'be unrelated to simple blood 
pressure reductions. Thus uncertainty has existed 
with regard to the exact mechanism by which 
propranolol retards development of experimental 
aortic aneurysms. Nevertheless, studies involving 
human beings with aortic aneurysms have suggested 
a significant reduction in aneurysmal expansion rate 
when patients are given [3-blockers. 3,4 
Prior experiments with blotchy mice have not as- 
sessed hemodynamic alterations accompanying 
[3-blocker eductions in aneurysm development. In
this study a marked reduction in heart rate was seen 
in [3-blocked blotchy mice, being 178 beats/min less 
than in normal littermates and 117 beats/min less 
than in untreated blotchy mice. No change in systolic 
blood pressure occurred with the [3-blockade used in 
this study. The two nonselective [3-blockers admin- 
istered, propranolol and nadolol, produced the same 
reduction in heart rate, as did the cardioselective 
[3-blocker, atenolol. Because these three [3-blockers 
have differing chemical and structural properties, it is 
very unlikely that they acted by a direct mechanism 
on collagen or elastin cross-linking. Although heart 
rate and blood pressure were the only hemodynamic 
parameters measured in the current experiments, it is 
reasonable to assume that both myocardial contrac- 
tility and cardiac output were also decreased. The 
cardiac properties of the [3-blockers would appear to 
predominate in reducing aneurysm size because the 
selective [31-antagonist was as effective as the two 
nonselective [3-blockers. 
LO alterations have not been previously hypothe- 
sized to be a significant factor in the development of
human aortic aneurysms. It is certainly unlikely 'that 
a deficiency in LO activity alone is a principal cause 
of aortic aneurysms in human beings, although such 
may be a contributing factor in certain aneurysm 
types. The first step in aneurysm formation is believed 
to be a degredative process such that elastin and 
eventually collagen are destroyed. An abnormal 
increase in protelytic enzyme activity might account 
for such a process. However, no studies have assessed 
an anabolic alteration as a prime cause of aneurysm 
development. Adult human beings do not possess the 
ability to synthesize appreciable amounts of new 
elastin. However, collagen synthesis can be increased 
in response to a variety of signals. Collagen destruc- 
tion can necessitate an increased emand for collagen 
synthesis with a concomitant eed for LO activity for 
cross-linking if homeostasis  to be maintained. A
patient with a relative deficiency in LO activity may 
be able to initially maintain the appropriate r parative 
processes to ensure usual aortic wall integrity. How- 
ever, over many decades the degradative process may 
overwhelm the limited reparative capabilities and 
result in aneurysm development. Likewise, regional 
LO activity differences within the arterial circulation 
may explain certain focal sites of aneurysmal devel- 
opment. Documentation of LO activity levels in 
human arterial tissues and aortic aneurysms has not 
been reported. 
A balance between extracellular matrix degra- 
dation and subsequent matrix synthesis exists in all 
aortic tissue. Thus any process that decreases matrix 
production or increases its degradation may result 
in a lessening of the aortic wall's tensile strength and 
increase the likelihood of aneurysm formation. If the 
amount of LO activity is fixed, as in the case of the 
blotchy mouse, with its finite ability to activate this 
enzyme because of a deficient cofactor, then the 
usual replacement of lost cross-linked collagen can 
not take place, and an aneurysm ay develop. This 
may explain why the blotchy mouse develops aortic 
aneurysms lowly over time as opposed to being 
born with large aneurysms. As a corollary, if the 
degradative process itself is slowed by lessening the 
physical stresses contributing to matrix turnover, 
then the limited amounts of active LO may be 
sufficient for needed reparative processes. The re- 
duction in hemodynamic forces accompanying the 
reduced heart rate in [3-blocked blotchy mice may 
result in a decrease in the degradative phase of the 
normal degradation-reformation of aortic matrix. 
We postulate that this is the mechanism by which 
[3-blockade results in a decrease in aneurysm de- 
velopment in blotchy mice. 
This is the first study to measure aortic LO 
activity directly in the blotchy mouse. Even though 
blotchy mice receiving [3-blockers exhibited an LO 
activity level that was the same as LO activity in 
untreated blotchy mice, they did not develop aneu- 
rysms at 4 months of age. Thus, in contrast o 
previous tudies, data from these experiments do not 
support he contention that [3-blockade acts directly 
to effect LO activity. Furthermore, it is unlikely that 
a direct effect of [3-blockers on collagen or elastin 
metabolism occurs independent ofLO cross-linking. 
The effect of [3-blockade on the inhibition of 
aneurysm development in blotchy mice may be 
related to reductions in heart rate. 
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D ISCUSSION 
Dr. Kenneth J. Cherry (Rochester, N.Y:). You have 
demonstrated what Others: have heretofore only assumed, 
that LO is f~du~ed in blbtChy mice with aneurysrns, and 
you have deVelOped aSSay methods that we can use. You 
also showed ra~erthan aSs~ed that propranoloi has no 
direct effect on LO. 
Previous Work by others with several different models 
failed to Show ~ beneficial effects of the selective [3-1 
drugs that yon have shown, and that failure has led in part 
to the supposition of a direct effect of propranolol on LO 
and, hence, cross-linkagel can you  suggest reasons why 
other invesfig~t0rs have no t been able to show the 
beneficial effects o f  the Selective [3-1 blockers that you have? 
BecaUse you have concluded that the reduction in heart 
rate is the major hemodynamic effect reducing these 
aneurysms, could other classes of drugs that are not 
antihypertensives per se, such as digoxin, be expected to 
have similar benefits? Should these be studied? 
You described no arch or thoracic aneurysms in these 
treated mice. Were there abdominal aortic aneurysms 
present in your treated mice? Although more uncommon 
they have been described in blotchy mice, Would these 
treated mice have a normal mouse-life if they were not 
killed? Is this applicable to human beings? Should we be 
using pr0pranoiol in patients with small aneurysms, and if 
so in what dose? 
Dr. Mohammed M. Moursi. Regarding the use of 
selective [3-1 antagonist, we used atenolol. We are not sure 
why there was the same effect as in nonselective 
[3-blockers, but  certainly atenolol produced the same 
reduction in heart rate and the same reduction in an- 
eurysmal size as the other [3-blockers. Potentially, the 
other studies, the human study that used propranolol and 
the turkey study that used that drug, were not using a 
proper dose and obtaining significant hemodynamic 
changes uch that they could have some reduction in their 
aneurysmal size. 
Can other compounds be used that reduce heart rate? 
Certainly. It's important with the tools available to assess 
LO activity to try to investigate many other different 
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compounds that would decrease myocardial forces that arc 
acting on the aneurysm. 
In terms of abdominal aneurysms, these mice live 
approximately a ear or a year and a half. Given the fact that 
propranolol in our hands reduced the aneurysm size to 
near-normal levels, we think that these animals could 
survive that long. We did not take any animals that far out 
because we wanted to have the tissue before rupture. 
Is this applicable to human beings? We believe it is. The 
causes of aneurysms in human beings are obviously 
multifactorial, but in normal aortas there is a degradative- 
reparative process that is stable. At some point in the age 
of a person, you get more degradation than repair, and if 
you have a deficiency in some compound, maybe LO or any 
other compound that might cross-link or facilitate the 
reparative process, then potentially ou shift to a more 
degradative process, and aneurysms develop. Anything to 
decrease that degradative process might be beneficial. 
Dr. Wil l iam H. Pearce (Chicago, Ill.). We have 
studied human tissue and found no difference in the elastin 
cross-links in patients receiving beta-blockers and those 
who are not. Therefore your data could be extrapolated to 
observation made in human beings. 
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